PTC Therapeutics (PTCT) Tops Q3 EPS by 19c

November 2, 2016 4:22 PM EDT
Get Alerts PTCT Hot Sheet
Trade PTCT Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($1.03), $0.19 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $23 million versus the consensus estimate of $19.76 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment